Mirum Pharmaceuticals, Inc. (MIRM)

86.57 +4.97 (+6.09%) USD  |  NASDAQ  |  Jan 09, 16:00
87.01 +0.44 (+0.51%) Pre-Market: 20:00
More

Mirum Pharmaceuticals Research and Development Expense (Annual): 140.10M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Pfizer Inc. 10.74B
XOMA Royalty Corp. 2.875M
Arcutis Biotherapeutics, Inc. 76.42M
Recursion Pharmaceuticals, Inc. 296.23M
Insmed, Inc. 598.37M